(αR)-α-[(Phenylmethoxy)methyl]-[1,1'-biphenyl]-4-ethanamine hydrochloride

this compound is a derivative of Sacubitril (S080895). Sacubitril is an antihypertensive drug used in combination with valsartan. The combination drug, valsartan/sacubitril, known during trials as LCZ696 and marketed under the brand name, Entresto, is a treatment for heart failure.